Source: BioPortfolio

CBAI: Cord Blood America Inc CBAI Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300

SummaryCord Blood America Inc CBAI is a provider of cord blood and cord tissue stem cell services. The company's preserved cord blood stem cells are used in the treatment of leukemia severe anemia metabolic and blood disorders and immune deficiencies among...

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
CEO Avatar

CEO

- -

CEO Approval Rating

- -/100

Read more